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The genes encoding apolipoprotein (apo) E and 
apoC1 are, together with the gene for apoC2, located 
in a conserved gene cluster on human chromosome 
19q12-13.2 and mouse chromosome 7. Although the 
significance of apoE as a ligand for receptor-mediated 
uptake of lipoprotein remnant particles is undisputed, 
the in vivo function of apoC1 and the possible inter­
action between apoE and apoC1 in the modulation of 
plasma cholesterol and triglyceride levels is far from 
understood. Our strategy to unravel the metabolic 
relationship between apoE and apoC1 in vivo is to 
first generate mice deficient in both apolipoproteins, 
enabling future production of transgenic mice with 
variable ratios of normal and mutant apoE and apoC1 
on a null background. Here we report the creation 
and characterization of mice deficient in both apoE 
and apoC1. As these genes are tightly genetically 
linked, double-deficient mice were obtained by two 
consecutive rounds of gene targeting in mouse 
embryonic stem cells. Surprisingly, double inactiva­
tion of the Apoe and Apoc1 gene loci as well as 
single inactivations at either one of these loci were 
found to affect also the RNA expression levels of the 
other gene members in the Apoe-c1-c2 cluster. This 
indicates that targeted insertions are not necessarily 
neutral for the expression of nearby gene members in 
a given gene cluster. Homozygous Apoe-c1 knockout 
mice are hypercholesterolemic, with serum choles­
terol levels of 12.5 ± 4.3 mM compared with 2.9 
± 0.5 mM in control mice, resembling mice solely 
deficient in apoE.
INTRODUCTION
The genes encoding apolipoprotein (apo) E and Cl, together 
with the pseudo APOCT gene and the gene for apoC2, are 
located within a 48 kb gene cluster on human chromosome 
19qI2-19ql3.2 (1). This entire linkage group is syntenic with 
a linkage group localized on mouse chromosome 7 (2). Also 
the gene organization of individual genes within the cluster is
highly conserved, with the exception that the mouse gene 
cluster is shorter and does not contain a pseudo A p o d ' gene (3).
ApoE is a major structural component of various plasma 
lipoproteins, including chylomicrons, very low density lipopro­
teins (YLDL) and their remnants. It is synthesized primarily 
in the liver, although most tissues produce apoE to various 
extents. The major physiological role of apoE in lipoprotein 
metabolism is that it serves as a ligand for the receptor- 
mediated clearance of lipoprotein remnants by the liver (4). 
Mutations in the APOE gene can lead to type III hyperlipo- 
proteinaemia, a disease associated with premature atheroscler­
osis (5). Mice deficient in apoE have been generated in our 
and other laboratories (6-8). These animals develop severe 
hypercholesterolaemia and atherosclerosis, with atherosclerotic 
lesions very similar to those observed in humans (9,10),
ApoCl principally resides on chylomicrons, VLDL and 
high-density lipoproteins (HDL), and is also mainly produced 
by the liver (11). In contrast to apoE, the in vivo function of 
apoCl is not well understood. We have reported previously 
that apoCl-deficient mice show an impaired receptor-mediated 
clearance of remnant lipoproteins (12). Contrary, in vitro work 
demonstrated that apoCl can block the apoE-mediated uptake 
of (3-VLDL by hepatic receptors (13,14), suggesting that lack 
of apoCl would lead to an enhanced uptake of lipoprotein 
remnants by the liver. Studies in transgenic mice overexpressing 
overlapping human APOE and APOC1 containing genomic 
fragments identified several elements controlling the tissue- 
specific expression of these genes (15). While the overexpres­
sion of APOC1 resulted in elevated levels of plasma cholesterol 
and triglyceride, the overexpression of both APOE and APOC1 
under control of the same regulatory complex had no effect 
on plasma lipid levels (15). This suggests that apoE and apoCl 
may interact coordinately to modulate the amount of plasma 
cholesterol and triglyceride (16).
To investigate the metabolic relationship between apoE and 
apoCl in vivo, we plan to use transgenic mice with graded 
expression levels of the human APOE and APOC1 genes. 
To avoid interference of the endogenous mouse genes, the 
transgenic mice overexpressing the human genes should be bred 
with Apoe-cl double-knockout animals. We have previously 
generated mice lacking either apoE (6) or apoCl (12). However, 
double-deficient mice cannot be obtained by cross-breeding 
Apoe and A p o d  null mutant mice, because these genes are
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closely genetically linked (4 kb apart from each other, see ref. 
3). One possibility to generate double-mutant mice would 
be to design a large deletion targeting vector, which upon 
homologous recombination would delete the Apoe and A p o d  
genes simultaneously. A similar approach has been used by 
Mombaerts and co-workers (17), who deleted a 15 kb genomic 
segment of the T-cell antigen receptor P-subunit locus* A 
disadvantage of this strategy, however, is that regulatory 
elements could be deleted as well. Another approach would 
be to target the Apoe and A p o d  genes sequentially. Because 
a heterozygous apo E-deficient embryonic stem (ES) cell line 
and a targeting vector for A p o d  were already available, we 
chose the latter option.
The following questions were addressed. Is it possible to 
disrupt closely adjacent genes by consecutive rounds of gene 
targeting, and if yes, how do single or multiple insertions 
affect the mRNA expression of other nearby apolipoprotein 
gene members in the A poe-d< 2  gene cluster? Furthermore, 
we were interested to know whether lack of apoC 1 in addition to 
lack of apoE would influence the severe hypercholesterolaemia 
observed in apoE-deficient mice (6-8).
Here we report that double-mutant mice are viable. Like 
apoE-deficient mice, homozygous Apoe-cl null mutants display 
hypercholesterol aemia, which becomes more severe on a high
fat/cholesterol diet. Strikingly, the RNA expression levels of 
genes in the Apoe-cl-c2 gene cluster are affected by the 
targeted disruption of single {Apoe or A p o d )  or multiple 
{Apoe plus A p o d )  genes, indicating that targeted insertions 
are not necessarily neutral for the expression of nearby gene 
members in a given gene cluster.
RESULTS
Generation of apoE-Cl-deficient mice
A replacement-type targeting vector, as used previously to 
disrupt the A p o d  gene (12), was transfected into a hetero­
zygous apoE-deficient E l4 ES cell line (7). This ES cell line 
was already resistant to G418, because a neomycin resistance 
(neor) gene had replaced exons 1 and 2 of the Apoe gene. 
To select for targeted clones, the A p o d  targeting construct 
contained a hygromycin B resistance (hygroBr) cassette and a 
herpes simplex virus thymidine kinase (HSV-iA:) gene. The 
selection strategy is outlined in Figure 1. In case the targeting 
of the A p o d  gene takes place in the wild-type chromosome, 
the endogenous 8.0 kb band will disappear upon Southern blot 
analysis of Hindlll digested DNA with probe A. A 9,3 kb 
band for the targeted A p o d  gene will become visible, next to
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Figure 1. Strategy for the disruption of the mouse Apoe-cl gene locus. The top two bars represent the wild-type and the A/we-mutant allele, both present in 
the ES cell line in which the experiment was performed. The middle bar depicts the targeting vector for the Apod  gene, the bottom bars the mutanL Apod  
locus after homologous recombination in the wild-type and the Apoe-mutant allele, respectively. Numbers 1-4 and the closed boxes denote exon sequences of 
the Apoe and Apocî genes; the horizontal bars represent the positions of probes A, B and C; the small arrows indicate the transcriptional orientation of the 
selection genes; the large arrows depict the size of the HindWl fragment upon Southern analysis with probe A. Abbreviations: E, £eoRI; H, ftmdlll.
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Effect of apoE-Cl-deficiency on apolipoprotein composition
VLDL (d <  1.006 g/ml) and HDL (d ~  1.063-1.21 g/ 
ml) were isolated from fasted wild-type, heterozygous and 
homozygous apoE-Cl -deficient animals by density ultracentri­
fugation, and subjected to SDS-polyacrylamide gel electro­
phoresis (SDS-PAGE) and protein staining (Fig. 3A). In 
VLDL, apoE is clearly absent in the homozygous double­
mutant mice and reduced in the heterozygous animals. Instead, 
apoAl appears in the VLDL of homozygotes, whereas apoA4 
is present in homozygous and heterozygous apoE-Cl -deficient 
mice. Most protein in HDL is apoAl. ApoB48 is normally 
not present in HDL, but because of high levels of VLDL/ 
LDL-sized particles (see also Fig. 4) residual amounts of these 
particles are also present in the 1.063-1.21 g/ml density 
fraction.
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Figure 4. Lipoprotein profiles of apoE-C 1-deficient and control mice on chow 
and a mild high fat/cholesterol diet. Sera from at least nine fasted controls, 
heterozygous and homozygous apoE-C l~deficient mice were pooled and size 
separated by FPLC. Mice had been fed a chow diet (top) or a mild high fat/ 
cholesterol diet (HFC) containing 15% fat and 0,25% cholesterol (bottom). 
Fractions 13-23 represent VLDL+LDL and fractions 24-34 represent HDL 
(based on the elution profile of human serum lipoproteins).
Because a 4-20% gradient gel cannot distinguish between 
the different apoC proteins and apoA2, Western blotting was 
required to demonstrate that apoCl is absent in the homozygous 
and reduced in the heterozygous mutant mice (Fig. 3B). When 
the filters were incubated with antibodies against apoE and 
apoB, similar results were obtained as with the gel stained for 
protein. The amount of apoC3 is comparable for all mice
(Fig. 3B).
Hypercholesterolaemia in apoE-C 1-deficient mice
As shown in Table 2, apoE-C 1-deficient mice are severely 
hypercholesterolaemic on a chow diet, with average serum 
cholesterol levels of 12.5 ±  4.3 mM compared with 2.9 ± 
0.5 mM in controls. Heterozygous double-deficient animals 
display normal serum lipid levels. There is no significant 
difference between male and female serum cholesterol levels. 
To determine the distribution of cholesterol among the lipopro­
tein fractions, fast protein liquid chromatography (FPLC) 
analysis was performed on pooled fasted mouse sera (Fig, 4, 
upper panel). In control and heterozygous mice, the main 
cholesterol carrier in serum is HDL, while at most 10% of 
total serum cholesterol is contained in the VLDL/LDL-sized 
fractions. In null mutants, however, most of the cholesterol 
(71%) is confined to the VLDL/LDL-sized fractions.
Upon feeding a mild high-fat/cholesterol (HFC) diet, con­
taining 15% fat and 0.25% cholesterol, serum cholesterol is 
increased eightfold in homozygous apoE-C 1 -deficient mice, 
as compared with controls fed the HFC diet (31 ±  10.1 mM 
and 3.8 ±  0.9 mM, respectively). The increase in total 
cholesterol is mainly found in the VLDL/LDL-sized fractions, 
as is depicted in the lower panel of Figure 4.
DISCUSSION
This paper describes the generation of mice deficient in both 
apoE and apoCl by two consecutive rounds of gene targeting 
in ES cells. Because the Apoe and A p o c l  genes are physically 
very close, and because the recombination distances across 
the pertinent area of mouse chromosome 7 are extremely small 
(2), double-deficient mice could not be obtained by cross­
breeding apoE- and apoCl-deficient mice. Instead, two selec­
tion markers (neor and hygroBr) were subsequently introduced 
into the same locus. The inactivation of the A p o d  gene in the 
second round of gene targeting was very efficient (1 in 3-4),
Table 2. Serum cholesterol and triglyceride levels in apoE-C 1 -deficient mice
Mouse Diet Cholesterol (mM) Triglyceride (mM)
6 ? <5 ?
4-/H- Chow 2.9 ± 0.5 3.0 ± 0.3 2.7 ± 0.5 0.7 ± 0.3 0.5 ± 0.2
+ /- Chow 2.4 ±  0.5 2.5 ± 0.4a 2.3 ± 0.6 1.6 ±  1.1 0.8 ± 0.4a
Chow 12.5 ± 4.3a,b 13.4 ± 4.5a,b 11.5 ± 3.9a,b 1 .0 ±  G.2a,c 0.7 ±  0.3
-H/+ HFC 3.8 ± 0.9d 4.4 ± 0.8c,d 3.2 ± 0.7 0.7 ± 0.3C 0.4 ±  0.3
+ /- HFC 3.6 ± 0.9d 4.3 ± 0.5c,d 2.9 ± 0.6 0.7 ± 0.4c,d 0.3 ± 0.1d
HFC 31.0 ±  l0.1aM 30.6 ±  10.9a’b,d 31.4 ± 9,23a,b,d 0.8 ±  0.1c 0.5 ±  0.2b
Serum triglycerides and serum cholesterol levels are given as mean ± SD. Each group contained 10 male and/or 10 female age-matched animals. + /+ ,  control 
mice; +/-, heterozygous apoE-C 1-deficient mice; homozygous apoE-C 1-deficient mice. HFC, mild high fat/cholesterol diet with 15% fat and 0.25% 
cholesterol.
a’ Significant difference (^<0.05) as compared with + /+  and 47- mice, respectively, on the same diet using non-parametric Mann-Whitney test.
Significant difference (P<0.05) as compared with female mice on the same diet using non-parametric Mann-Whitney test.
^Significant difference (P<0.05) as compared with mice of same genotype on chow diet using non-parametric Mann-Whitney test.
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and comparable with the targeting frequency previously found 
in wild-type ES cells (12). Both wild-type and already targeted 
alleles recombined with equal efficiency, indicating that the 
proximity of the neor gene in the apoE-deficient locus did not 
affect the frequency of homologous recombination. Moreover, 
the presence of both of these resistance genes and the two 
rounds of transfection and selection of the ES cells did not 
interfere with the germline potency of the cell line.
While studying the mRNA levels of genes in the Apoe-cl- 
c2 gene cluster in apoE-, apoC- and double-deficient mice, 
some conspicuous observations were made. Not only is the 
expression of the targeted gene reduced by the respective 
mutation, also other genes in the cluster are influenced by the 
insertion of a targeting vector in the locus. There are several 
ways how this could occur. First, it is possible that a reduction 
of apoE protein would lead to a down- or upregulation of the 
A p o d  or Apoc2 gene, or both, via an indirect metabolic effect 
in the lipoprotein metabolism. In that case, the amount of 
protein of the targeted gene would be critical for the effect on 
the expression of the other genes in the cluster. This type of 
metabolic interaction is seen in transgenic mice containing the 
gene for human cholesteryl ester transfer protein, in which the 
mRNA for the LDL receptor is down-regulated (18). Second, 
the effect might be due to changes in genomic structure of the 
entire apolipoprotein cluster by the homologous integration of 
the targeting vectors. The insertion of one or two selection 
cassettes that include promoter and enhancer elements may 
deregulate the transcription of neighbouring genes in a distance- 
and position-dependent manner. Work in transgenic mice 
revealed that expression in liver of the human APOE and 
APOC1 genes requires a common m-acting regulatory domain, 
which is located about 9 kb downstream of the APOC1 
promoter (19,20). A similar hepatic control element was 
identified in mice between A p o d  and Apoc2 (J.Smith, pers, 
comm.). It is conceivable that the newly introduced promoter(s) 
and gene(s) (the hygroBr and neor genes, both driven off of 
the ffc-promoter and a mutant polyoma enhancer) will compete 
for this m-acting regulatory domain with apolipoprotein pro­
moters. Consequently, this would lead to reduced expression 
of these genes. A targeted insertion of a hygror cassette into 
the human |3-globin locus control region (LCR) in a mouse/ 
human hybrid erythroid cell line inactivated the downstream 
located p-globin gene (21). The inactivation was suggested to 
be the result of interaction of LCR elements with the proximal 
enhancer/promoter introduced by the hygror cassette, pre­
venting the normal interaction between the LCR and the p- 
globin gene promoter. Similarly, competition between the 
genes in the Apoal -c3-a4 gene cluster for a shared regulatory 
sequence has been proposed by Maeda et ai (22) as an 
explanation for the observed reduction of expression of the 
Apoal and Apoa4 genes in intestine of homozygous apoC3- 
deficient mice.
Which of the above mentioned options for the altered gene 
expression of the Apoe-cl-c2 cluster in the various knockout 
animals is true cannot be deduced from our data. A metabolic 
interaction between apoE and apoCl is quite feasible, because 
work in transgenic mice already suggested that these two 
proteins may interact coordinately to modulate plasma lipid 
levels (16). Although there are multiple shared regulatory 
elements for the Apoe and A p o d  genes (15), it is not clear 
whether these elements also regulate the expression of Apoc2.
The integration of the targeting vector did not delete any of 
the known regulatory sequences. If the hepatic control region 
does not regulate the expression of Apoc2 but only controls 
the expression of Apoe and A p o d , then the reduced levels of 
these latter genes in the homozygous knockout mice could be 
explained by the competition model. As the expression of 
Apoc2 is decreased in homozygous apoCl - and double-deficient 
animals, normal in homozygous Apoe knockout mice and 
increased in heterozygous apoE-deficient mice, it is hard to 
explain these results with the competition model. If the 
expression of A p o d  is regulated by the same ds-acting control 
region as the Apoe and A p o d  genes, then the position of the 
enhancer relative to the gene (5' of Apoc2 and 3' of Apoe and 
A p o d )  and the distance between the enhancer and the gene 
might play a part.
The overt phenotype of the apoE-C 1 -deficient mice is similar 
to that of Apoe knockout mice (6-8), that is hypercholesterolae- 
mia on a chow diet, which becomes more severe on a 
high-fat/cholesterol diet. Interestingly, heterozygous double- 
deficient mice fed a chow diet display a lower serum cholesterol 
level than their wild-type littermates. This difference is signi­
ficant for males. This unexpected finding was also observed 
in heterozygous apoE-deficient mice fed a chow diet (6), 
although in that case the difference was only significant for 
females. At this moment, we do not know the reason for these 
observations.
On a chow diet, serum cholesterol levels in the double­
deficient mice seem to be somewhat lower than in apoE- 
deficient mice [12.5 ±  4.3 mM and 19.3 ± 5.5 mM (6), 
respectively], whereas serum cholesterol is comparable for 
both types of mice on the HFC diet. The difference on chow 
might be caused by difference in age between the apoE- 
deficient and the double-mutant mice, as we have previously 
shown that serum cholesterol in apoE-deficient mice is age- 
dependent (6), but might also be due to absence of apoCl in 
addition to lack of apoE. It will be interesting to see whether 
these mice develop atherosclerosis to a similar extent as mice 
solely deficient in apoE (7-10), and if heterozygous Apoe-cl 
knockout mice fed a severe high-fat diet would also develop 
gender-dependent atherosclerosis, as we have observed in 
heterozygous Apoe null mutants (6).
When animals carrying a human transgene are studied, a 
null background of the mouse counterpart of that gene would 
be the ideal genetic environment of the study. Especially if 
the interaction between two transgenes is investigated, it is of 
great importance that there is no endogenous expression of 
these genes, so that there will be no compensatory up- or 
downregulation of the endogenous mouse genes. This can be 
reached by two rounds of crossbreeding of mice carrying a 
transgene with mice deficient in the endogenous protein of 
that gene. In this respect, the apoE-C 1-deficient mice are 
extremely valuable for future use in studies on the metabolic 
relationship between apoE and apoCl in vivo.
MATERIALS AND METHODS
Cell culture and transfection
An EI4 ES cell line with one functional and one disrupted Apoe allele (7, 
kindly provided by Dr A.S.PIump, Rockefeller University, New York) was 
used as the source of ES cells. The Apod  gene was targeted with a 
replacement type vector designed to disrupt solely the Apod  gene, as described 
previously (12).
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ES cells were cultured and subsequently selected on hygroBr mouse 
embryonic fibroblasts derived from mice deficient in muscle creatine kinase 
(23). ES cells were electroporated in the presence of 25 pg/ml linearized 
vector DNA at 4.0 kV/cm in a TA750 transfection apparatus (Krilss GmbH 
Hamburg, Germany). Selection took place with 300 [ig/ml hygromycin B 
(ICN Biochemicals, Cleveland, OH) and 0.2 |iM FIAU (l-[2-deoxy, 2- 
fluoro-p-D-arabinofuranosyl] 5-iodouracil), Bristol Myers, New York, NY) as 
described previously ( 12).
Generation of chimeric and apoE-C 1-deficient mice
Targeted clones were injected into C57BL/6 recipient blastocysts and chimeras 
were obtained. Male chimeras were mated with C57BL/6 females, and 
germline transmission was scored by the presence of agouti fur in the offspring. 
Transmission of the Apoe-cl mutation was assessed by Southern blot analysis 
of tail tip DNA. Heterozygous mutants were interbred to obtain homozygous 
apoE-C 1-deficient mice. Animals were bred and housed under standard 
conditions in the transgenic animal facilities of the Central Animal Laboratory 
of the Medical Faculty, Nijmegen University.
Genomic Southern blot analysis
ES cell clones were lysed in 0.5 ml of 0.5 M Tris-HCI, pH 9.0, 20 mM 
EDTA, 10 mM NaCl, 1% SDS and 100 |ig/ml proteinase K at 55°C overnight. 
DNA was purified by phenol extraction and ethanol precipitation. Tail tip 
DNA was prepared as previously described (6).
Aliquots of approximately 5 fig of DNA were digested with Hindill and 
DNA fragments were resolved on 0,7% (w/v) agarose gels, transferred to 
Biotrace HP nylon membranes (Gelman Sciences, Ann Arbor, MI) and 
hybridized to a genomic probe A, which is located 5' to the targeting vector 
(see Fig. 1). Genomic probes were isolated by random subcloning of a Sau3A 
digested cosmid, carrying the Apoe-cl-c2 cluster.
Northern blot analysis
Total RNA wus isolated individually from three to four livers per genotype 
using the RNAZOL procedure (Cinna/Biotecx, Houston), Each RNA sample 
was loaded on to four individual gels. RNA samples (10 pg per lane) were 
size separated by electrophoresis through a denaturing agarose gel (1% w/v) 
containing 7.5% formaldehyde and transferred to a nylon membrane (Hybond 
N+, Amersham) according to the manufacturer’s recommendations. Blots 
were subsequently hybridized with 32P-labelled mouse cDNA probes for Apoe 
(1.1 kb insert of pmEUC18, ref. 24), Apocl (derived from mAPOClcl6 , ref. 
25) and Apocl {derived from mAPOC2cl, ref 26). As an internal standard, blots 
were also hybridized with a rat glyceraldehyde~3-phosphate dehydrogenase 
(GAPDH) cDNA probe. The intensity of the hybridization signal was quantified 
with a Phosphor Imager (Molecular Dynamics), using the software program 
Imagequant (Molecular Dynamics), and related to the level of GAPDH mRNA.
Lipoprotein isolation
The individual lipoprotein fractions (VLDL: 1.006; IDL+LDL: d = 1.006-
1.063; HDL: d ~ 1.063-1.21 g/ml) were isolated from pooled serum by 
sequential ultracentrifugation, as previously described (12). The amount of 
protein was determined according to Lowry (27).
For FPLC size fractionation of lipoproteins, 200 ju.1 of pooled serum from 
at least nine fasted mice per group was injected on to a 25 ml Superose 6 
prep grade column (Pharmacia, Uppsala, Sweden), and eluted at a constant 
flow rate of 0.5 ml/min with PBS (pH 7.4). The effluent was collected in 0.5 
ml fractions, and cholesterol and triglyceride concentrations were measured 
enzymatically in each fraction, as described in ‘lipid and lipoprotein analyses’. 
The lipoproteins were identified on the basis of the elution profile of human 
serum lipoproteins.
SDS-PAGE and Western blot analyses
For SDS-PAGE mouse VLDL and HDL was loaded on a 4-20% gradient 
gel. Proteins were detected by staining with Coomassie blue.
For Western blot analysis samples of VLDL-protein were size-separated 
by SDS-PAGE using 4—20% gradient gels. Proteins were transferred to 
nitrocellulose membranes (Schleicher & Schuell, Dassel, Germany) followed 
by incubation with polyclonal rabbit anti-mouse apoCl, apoC3 and apoE 
(kindly provided by Dr K.Weisgraber, Gladstone Foundation Laboratories for 
Cardiovascular Disease, San Francisco, CA) and with rabbit antimouse apoB. 
Goat antirabbit IgG conjugated to peroxidase (Nordic Immunology, Tilburg, 
the Netherlands) was used as a second antibody and detection was performed 
by the immunoperoxidase procedure, using 4-chloro-l-naphtol as substrate.
Lipid and lipoprotein analyses
After an overnight fasting period (16-17 h), approximately 150 jllI of whole 
blood was obtained from each individual mouse through tail bleeding. Levels 
of total serum cholesterol and triglyceride (without measuring free glycerol) 
were determined using Boehringer Mannheim enzymatic assay kit #236691 
and Sigma GPO-Trinder kit #337~B, respectively.
Diets
Mice were given free access to water and food. A regular breeding chow diet 
(RMH-B) containing 6.2% fat and a semisynthetic mild HFC diet containing 
15% cocoa butter, 0.25% cholesterol, 40,5% sucrose, 10% cornstarch, 1% 
corn oil, and 6% cellulose (all percentages are by weight) were used. The 
latter diet was composed essentially according to Nishina and co-workers 
(28). Diets were purchased from Hope Farms, Woerden, the Netherlands.
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ABBREVIATIONS
Apo, apolipoprotein; VLDL, very low density lipoprotein(s); HDL, high- 
density lipoprotein(s); kb, kilobase pairs; ES, embryonic stem; neor, neomycin 
resistance; hygroBr, hygromycin B resistance; HSW-tk, herpes simplex virus 
thymidine kinase; SDS-PAGE, SDS-polyacrylamide gel electrophoresis; LDL, 
low-density lipoprotein(s); FPLC, fast protein liquid chromatography; HFC, 
mild high fat/cholesterol diet; LCR, locus control region; FIAU, l-[2-deoxy,
2-fiuoro-p-D-arabinofuranosyl] 5-iodouracil; GAPDH, glyceraldehyde-3-phos- 
phate dehydrogenase.
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